Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Shanghai Pharmaceuticals Holding Co Ltd
Revenue
Shanghai Pharmaceuticals Holding Co Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Revenue
¥260.3B
|
CAGR 3-Years
11%
|
CAGR 5-Years
10%
|
CAGR 10-Years
13%
|
Sinopharm Group Co Ltd
HKEX:1099
|
Revenue
¥591.6B
|
CAGR 3-Years
11%
|
CAGR 5-Years
12%
|
CAGR 10-Years
15%
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Revenue
¥151.8B
|
CAGR 3-Years
13%
|
CAGR 5-Years
13%
|
CAGR 10-Years
17%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Revenue
¥49.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
17%
|
Huadong Medicine Co Ltd
SZSE:000963
|
Revenue
¥40.3B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
10%
|
|
C
|
China National Accord Medicines Corp Ltd
SZSE:000028
|
Revenue
¥75.5B
|
CAGR 3-Years
8%
|
CAGR 5-Years
12%
|
CAGR 10-Years
14%
|
See Also
What is Shanghai Pharmaceuticals Holding Co Ltd's Revenue?
Revenue
260.3B
CNY
Based on the financial report for Dec 31, 2023, Shanghai Pharmaceuticals Holding Co Ltd's Revenue amounts to 260.3B CNY.
What is Shanghai Pharmaceuticals Holding Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
13%
Over the last year, the Revenue growth was 12%. The average annual Revenue growth rates for Shanghai Pharmaceuticals Holding Co Ltd have been 11% over the past three years , 10% over the past five years , and 13% over the past ten years .